Literature DB >> 9577412

Human leukocyte antigen B27 allele is not correlated with fibrodysplasia ossificans progressiva.

G T Calvert1, E M Shore.   

Abstract

Fibrodysplasia ossificans progressiva is a rare heritable disorder of connective tissue characterized by skeletal malformations and by progressive heterotopic ossification. It has been suggested that the genetic marker human leukocyte antigen B27 may be associated with fibrodysplasia ossificans progressiva, as it is with ankylosing spondylitis, another disorder with less severe hyperostosis. Genomic deoxyribonucleic acid from 23 classically affected patients with fibrodysplasia ossificans progressiva was screened for the human leukocyte antigen B27 allele by polymerase chain reaction. Only two of the 23 patients (9%) with fibrodysplasia ossificans progressiva who were examined showed the presence of the human leukocyte antigen B27 allele, an incidence that corresponds to the 8% frequency of individuals within the general population not affected with ankylosing spondylitis. These data suggest that the human leukocyte antigen B27 allele does not occur more commonly in the genotype of patients with fibrodysplasia ossificans progressiva than in the general population, and that the pathogenesis of heterotopic bone in fibrodysplasia ossificans progressiva differs from that of ankylosing spondylitis and other human leukocyte antigen B27 positive disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577412

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

1.  Fibrodysplasia ossificance progressiva: A familial presentation.

Authors:  Shwetal Uday Pawar; Sarita Sahoo; Ashmi Manglunia; Gundu Hari Tilve
Journal:  Indian J Nucl Med       Date:  2015 Jul-Sep

2.  Stone man: a case report.

Authors:  Hamed Mortazavi; Majid Eshghpour; Mahdi Niknami; Morteza Saeedi
Journal:  Iran J Radiol       Date:  2012-12-27       Impact factor: 0.212

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.